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Background: Routine monitoring of patients on antiretroviral therapy (ART) is crucial for measuring program
success and accurate drug forecasting. However, compiling data from patient registers to measure retention in ART
is labour-intensive. To address this challenge, we conducted a pilot study in Malawi to assess whether patient ART
retention could be determined using pharmacy records as compared to estimates of retention based on
standardized paper- or electronic based cohort reports.
Methods: Twelve ART facilities were included in the study: six used paper-based registers and six used electronic
data systems. One ART facility implemented an electronic data system in quarter three and was included as a
paper-based system facility in quarter two only. Routine patient retention cohort reports, paper or electronic, were
collected from facilities for both quarter two [April–June] and quarter three [July–September], 2010. Pharmacy stock
data were also collected from the 12 ART facilities over the same period. Numbers of ART continuation bottles
recorded on pharmacy stock cards at the beginning and end of each quarter were documented. These pharmacy
data were used to calculate the total bottles dispensed to patients in each quarter with intent to estimate the
number of patients retained on ART. Information for time required to determine ART retention was gathered
through interviews with clinicians tasked with compiling the data.
Results: Among ART clinics with paper-based systems, three of six facilities in quarter two and four of five facilities
in quarter three had similar numbers of patients retained on ART comparing cohort reports to pharmacy stock
records. In ART clinics with electronic systems, five of six facilities in quarter two and five of seven facilities in
quarter three had similar numbers of patients retained on ART when comparing retention numbers from
electronically generated cohort reports to pharmacy stock records. Among paper-based facilities, an average of 13 4
hours was needed to calculate patient retention for cohort reporting using patient registers as compared to 2.25
hours using pharmacy stock cards.
Conclusion: The numbers of patients retained on ART as estimated using pharmacy stock records were largely
similar to estimates based on either paper registers or electronic data system. Furthermore, less time and staff effort
was needed to estimate ART patient retention using pharmacy stock records versus paper-based registers.
Reinforcing ARV stock management may improve the precision of estimates.
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Globally, the number of HIV-infected individuals on anti-
retroviral therapy (ART) grew from 400,000 in 2004 to
over 5.2 million by the end of 2009 [1]. In sub-Saharan
Africa alone, approximately 3.9 million HIV-infected indi-
viduals received ART by December 2009, up from about
25,000 patients in 2002 [1]. The dramatic pace of ART
scale-up brings huge challenges in effective and accurate
monitoring of expanding ART programs including ARV
drug management. Routine, accurate monitoring of
patients who start ART and, most critically, those who are
retained on ART is crucial both for measuring program-
matic success and monitoring drug supplies. In resource-
poor settings in sub-Saharan Africa, innovative, precise,
and low-cost methods are needed to effectively track
patients and drug supplies.
Like many of its neighbours, Malawi’s ART program
expanded rapidly. As of December 31st, 2009, Malawi
reported a total of 271,105 patients on ART. Of 377
ART facilities, 46 registered more than 2,000 patients
each and 11 sites registered more than 5,000 patients
[2]. Currently, ART facilities in Malawi use simple, stan-
dardized monitoring systems to record the number of
new ART initiations, continuing ART patients, and
transfer-in patients every quarter. This quarterly summa-
tion is referred to by the Malawi Ministry of Health
(MoH) as the Quarterly ART Cohort Report [3]. Despite
the relative simplicity of the ART cohort reporting tools,
routine accurate reporting of the numbers of patients
retained on ART is complicated. To report accurately,
ART facilities must know both the number of patients
who ever started on ART [determined from the ART
treatment cards and registers] and the outcome of all
patients at the end of every quarter. In Malawi, five stan-
dardised outcomes are reported: 1) alive and on therapy
(implies ART retention); 2) dead; 3) stopped treatment;
4) transferred to another facility, and 5) lost to follow-up
(defined as missing a clinic appointment by two months
or more). The number “alive and on therapy” in a facility
is calculated as the number ever started on ART minus
deaths, stops, transfers to other clinics, and lost to fol-
low-up.
As the number of people initiated on life-long ART
grows in Malawi, other ways of estimating ART retention
are needed. Compiling the quarterly ART cohort report is
very labour intensive for clinics that use paper-based reg-
isters: it requires reviewing all individual treatment cards,
updating the clinic register, and aggregating patient out-
comes. The time and effort needed to complete this exer-
cise raise significant concerns about the time allocation
for health workers and the quality of data collection, espe-
cially as the number patients retained on ART increases.
One possibility for an improved monitoring system,
piloted in Malawi and elsewhere, is an electronic patientmanagement systems [4]. However, electronic systems re-
quire significant upfront hardware costs and well-trained
personnel to monitor system performance creating bar-
riers to nationwide scale-up. An alternate possibility for
low resource settings is to use pharmacy stock records to
streamline the monitoring process [5,6]. If well kept, phar-
macy stock information on drug dispensation may provide
an accurate measure of ART retention over a defined time
period. We, therefore, piloted a study in Malawi to deter-
mine whether estimates of patient retention on ART from
pharmacy stock records would reflect a similar level of
precision as compared to the current estimates using ei-
ther paper- or electronic-based registers. We also com-
pared the personnel time taken to compile ART patient
retention data for the cohort report using paper-based pa-
tient registers versus pharmacy stock records.
Methods
Sample characteristics
We used a purposeful sampling technique to select 12
ART facilities representing all levels of health delivery fa-
cilities (central hospitals, district hospitals and health
centres) and both paper-based and electronic systems of
data management. Six selected ART sites used paper-
based systems (2 district hospitals, 1 mission hospital
and 3 rural health centres) and six used a real-time elec-
tronic patient management data system (2 central hospi-
tals and 4 district hospitals). Both paper and electronic
data systems collect similar information and report the
same standardized information for the ART cohort
report.
The Malawi ART program uses three predominant
ARV regimens: first-line - Stavudine Lamivudine Nevira-
pine (d4T 3TC NVP); alternative first line -Zidovudine
Lamivudine Nevirapine (AZT 3TC NVP) or Stavudine
Lamivudine + Efavirenz (d4T 3TC + EFV) or Zidovudine
Lamivudine + Efavirenz (AZT 3TC + EFV); and second
line –Zidovudine Lamivudine + Tenofovir + Lopinavir
Ritonavir) (AZT 3TC + TDF + LPV/r) for adults; Didano-
sine + Abacavir + Lopinavir (ddl ABC LPV/r) for chil-
dren. D4T 3TC NVP and AZT 3TC NVP are fixed dose
combinations for first-line and alternative first line
respectively.
Data collection
We collected data from routine cohort reports of patients
retained in therapy and pharmacy stock records for quar-
ter 2, April – June 2010 and quarter 3, July – September,
2010 from ART facilities using either paper- and
electronic-based systems. Facilities with electronic-based
systems were mainly included in the pilot to validate ART
retention estimates. We used variables from the cohort re-
port. First, we used, the number of new patients registered
which includes both new ART initiations and transfer-in
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on therapy at the end of a quarter, calculated by recording
the number of patients ever started minus those who died,
stopped, transferred-out and lost to follow-up at end of
the quarter. Also, the cohort report had the number of
patients retained in therapy stratified by type of regimen
(first- and second-line). In each paper-based site, we deter-
mined time needed to compile a cohort report from ART
registers through in-person interviews with those respon-
sible for data reporting. In sites with electronic data sys-
tems, production of the cohort report data is quick,
requiring only simple, pre-set commands.
Pharmacy ARV stock data were also collected from
all ART facilities using the same methods, regardless
of whether paper- or electronic-based systems were
used for patient management. The number of ART
continuation bottles [containers of tablets for 30 days
for all regimen types] were documented at the start
and end of a specific quarter using pharmacy stock
cards. Data for re-distribution or expiration were
also recorded from pharmacy stocks and delivery
receipts. These data were used to calculate the total
number of bottles dispensed by the clinic to patients
in the specific quarter. Although dispensing intervals
varied as patients received 0.5, 1, 2, 3 or more bot-
tles for intervals of 2 weeks, 1, 2, 3 or more months,
the average rate of dispensing per patient during the
quarter was assumed stable over time. The number
of patients retained on therapy at the end of the
quarter was calculated by taking a) the number of
new patients starting ART (both ARV naïve and
transfer-in patients); b) multiplying this number by
1.5 as new patients use, on average, 1.5 ARV bottles
per quarter; then, c) subtracting this number from
the number of bottles of ART used in three months;
and finally, d) dividing this number by 3 to calculate
the number of patients on ART.Calculating patients retained on ART using ARV stock
data
Step 1*
Number of continuation ART bottles (First line, al-
ternative first line second line) at start of the quarter
(A). Number of continuation ART bottles (First line,
alternative fist line, second line) at end of the quar-
ter (B). Number of continuation ART bottles used:
A – B = (C). C is the number of bottles for follow
up patients from previous quarters and those regis-
tered in the current quarter at the ART facility * this
calculation includes removal and addition of stocks
and continuation bottles lost because of expiry,
loans, theft, etc.Step 2
Number of new patients starting ART in the quarter.
(D) Number of continuation ART bottles used by new
patients in quarter = D x 1.5 = E. E is the average num-
ber of bottles during follow-up for patients registered in
the current quarter.
Step 3
Number of continuation ART bottles used = C Number
of continuation ART bottles used by new patients = E.
Number of continuation bottles of ART used by follow-
up patients = C – E = F. F is the number of bottles for
follow-up patients from previous quarters only. Number
of patients on follow-up = F divided by 3 = G.
Step 4
Number of new patients retained on ART = D. Number
of follow-up patients retained on ART = G. The total
number retained on ART = D + G = H*. This final num-
ber could also be stratified according to type of regimen
depending on available information.
Data analysis
Analysis was stratified by type of data system. First,
among those ART facilities with paper-based ART pa-
tient registries, the number of patients retained on ART
was compared between routine cohort reports from
paper-based systems and pharmacy-based records. We
chose an acceptable tolerance of 5.0% above or below
the routine cohort report estimates when comparing
estimates as an incorrect estimate of patient numbers by
more than 5.0% may result in huge over quantification
and supply of ARV drugs to ART facilities. In ART facil-
ities with electronic ART data systems, we compared pa-
tient retention as determined by electronic cohort report
versus paper-based pharmacy records. In case of discrep-
ancy of more than 5.0% between the 2 sources, we were
not able to determine which system was more accurate.
In paper-based facilities, brief qualitative interviews
with clinical officers and data clerks were conducted to
determine time taken to compile the cohort reports.
Ethics Approval
The study was approved by the Malawi National Health
Science Research and the Ethics Advisory Group of The




Data were collected from 12 ART facilities between April
and September, 2010. The numbers of ART patients ever
registered at these sites by September 2010 ranged from
1,194 at Chipini Health Centre to 13,961 at Queen Elizabeth
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varied from 781 at Chipini Health Centre to 7,774 at Queen
Elizabeth Central Hospital.ART retention estimates in facilities using paper-based
monitoring systems
Of six ART facilities using paper-based data system,
overall estimates of patients retained on ART from the
cohort report versus pharmacy stock cards were similar
in two of three health centres and one of three district-
level hospitals in quarter two (Table 1). In quarter three,
estimates from both methods showed similar numbers
of patients retained across two health centres and in two
of three district-level hospitals. One district ART facility
started using an electronic data system in quarter three
and was, therefore, excluded from quarter three analysis.
Table 2 shows the level of agreement of the numbers
of patients retained on first-line ARV regimens accord-
ing to paper-based cohort reports and pharmacy stock
records. One of three health centres had similar reten-
tion estimates in both quarters. However, none of the
district ART facilities had similar number of patients on
the first-line regimen in quarter two and, in quarter
three, two district-level hospitals had similar ART reten-
tion estimates. Further analysis for the second-line ARV
regimen was not feasible as the numbers were small and
prevented meaningful comparison.ART retention estimates in facilities using electronic
monitoring systems
Among six ART facilities with electronic data systems in
quarter 2, five of the six facilities had similar estimates
of patients retained on ART according to the cohort re-
port versus pharmacy stock cards (Table 3). In quarterTable 1 Comparison of total numbers of patients retained on
cards data in paper-based ART facilities
Quarter two (April to June 2010)
ART facility Clinic Pharmacy stock cards Precisio
cohort report
Health Centres
Bangwe 1,567 1,575 101%
Chipini 779 790 101%
Ndirande 1,886 1,606 85%
Total 4,232 3,971 94%
District Hospital
Mchinji 2,027 2,455 121%
Mangochi₣ 4,519 4,962 110%
Malamulo 2,140 2,186 102%
Total 8,686 9,603 111%
₣Mangochi was excluded in quarter three analysis because of the introduction of an
for ART retention estimates from pharmacy stock records versus clinic cohort reporthree, five of the seven ART facilities had similar num-
bers of patients retained on therapy using the cohort re-
port versus pharmacy stock cards. Mangochi District
Hospital was included in quarter three comparisons be-
cause it adopted the electronic data system.
Table 4 shows the comparison of number of patients
retained on the first-line regimen based on estimates be-
tween clinic cohort report and pharmacy stock records
for quarter two and three. Three of four district-level
hospitals and one central hospital had similar numbers
of patients on first-line regimen in quarter two; two of
five district ART hospitals and both central hospitals
had similar numbers of patients on the first-line regimen
in quarter three.Workload and time required to compile a cohort report
Table 5 shows time required to compile cohort reports
in ART facilities that used a paper-based system. On
average, facilities with more than 1,200 patients on ART
took 13.4 hours to compile the report; an additional 5
hours were required for report verification by the ART
supervision team. In comparison, estimation of cohort
data from pharmacy stock cards took 2.25 hours on
average in these same facilities. The cost associated with
personnel time invested in generating the cohort reports
was not included as no additional costs are incurred.Discussion
This is one of first studies to explore the feasibility of
using pharmacy ARV stock cards for estimating the
number of patients retained on ART in resource-
constrained settings. Four of the five ART facilities with
paper-based data systems in quarter 3 had acceptable
estimates of patients retained on ART as, calculatedART between clinic cohort reports and pharmacy stock
Quarter three (July to September 2010)










electronic data system. *Precision is a measure of the degree of agreement
t estimates.
Table 2 Comparison of numbers of patients retained on first-line ARV regimen between clinic cohort reports and
pharmacy stock cards in paper-based ART facilities
Quarter two (April to June 2010) Quarter three (July to September 2010)
First -line regimen First-line regimen
ART facility Clinic Pharmacy stocks cards Precision (%)* Clinic Pharmacy stocks cards Precision (%)*
cohort report cohort report
Health Centre
Bangwe 1,554 1,639 105% 1,675 1,676 100%
Chipini 655 788 120% 692 909 131%
Ndirande 1,841 1,605 87% 1,952 2,071 106%
Total 4,050 4,032 100% 4,319 4,656 108%
District Hospital
Mchinji 1,995 2,222 111% 2,061 2,203 103%
Mangochi₣ 4,516 4,962 110% - -
Malamulo 2,038 1,852 91% 2,113 2,189 99%
Total 8,683 9,036 104% 4,345 4,392 101%
₣Mangochi was excluded in quarter three analysis because of the introduction of an electronic data system. *Precisions is a measure of the degree of agreement
for ART retention estimates from pharmacy stock records versus clinic cohort report estimates.
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cohort report versus estimates using pharmacy stocks
records. Among those with electronic systems in both
quarters two and three, five ART facilities had acceptable
levels of agreement between the two estimation meth-
ods. The study also suggests that estimation of patients
retained on ART using pharmacy stock data may be
cost-effectiveness in terms of staff time required to com-
pile the data.
Although most paper-based ART facilities showed
similar estimates of patients retained using patient regis-
ters or pharmacy stock cards, inaccuracies of theseTable 3 Comparison of numbers of patients retained on ART
and paper-based pharmacy stock cards in electronic-based A
Quarter two (April to June 2010)
ART facility Clinic ¥ Pharmacy stocks cards Precisio
Cohort report
District Hospital
Dedza 1,921 1,852 96%
Martin Preuss 6,524 6,493 100%
Salima 2,520 2,395 95%
St Gabriel 1,656 1,548 93%
Mangochi₣ - - -
Total 12,621 12,288 97%
Central Hospital
Lighthouse 6,374 6,281 99%
Queens Elizabeth 7,408 7,082 96%
Total 13,782 13,363 97%
₣Mangochi was included in quarter three analysis because of the introduction of an
a measure of the degree of agreement for ART retention estimates from pharmacyestimates may be caused by several factors. First, the
paper-based system is prone to data incompleteness. A
previous study looking at the extent of data inaccuracies
reported up to 24% of ART registrations missing in the
paper ART registers in comparison to electronic data
records [7]. Second, the variations in pharmacy-based
retention estimates might be due to differences in phar-
macy operations across the facilities. In the three or four
district-level hospitals that used paper-based systems,
ARV drugs were stored in the main district pharmacy
for the respective hospital. Drug disbursement or trans-
fers to the ART facility within these hospitals arebetween electronically generated clinic cohort reports
RT facilities
Quarter three (July to September 2010)











electronic data system. ¥ Electronically generated cohort report. *Precisions is
stock records versus clinic cohort report estimates.
Table 4 Comparison of numbers of patients retained on first-line ARV regimen between electronically generated clinic
cohort reports and paper-based pharmacy stock cards in electronic-based ART facilities
Quarter two (April to June 2010) Quarter three (July to September 2010)
First -line regimen First-line regimen
ART facility Clinic¥ Pharmacy stocks cards Precision (%)* Clinic Pharmacy stocks cards Precision (%)*
cohort report cohort report
District Hospital
Dedza 1,868 1,852 99% 1,949 1,955 100%
Martin Preuss 6,514 6,471 99% 7,024 6,806 97%
Salima 2,436 2,395 98% 2,586 2,429 94%
St Gabriel 1,412 1,542 109% 1,447 1,679 116%
Mangochi₣ - - - 4,145 2,326 56%
Total 12,230 12,260 17,645 15,195 86%
Central Hospital
Lighthouse 6,161 6,023 98% 6,264 6,152 98%
Elizabeth 7,253 6,840 94% 7,592 7,604 100%
Total 13,414 12,863 96% 13,856 13,756 99%
₣Mangochi was included in quarter three analysis because of the introduction of an electronic data system. ¥ Electronically generated cohort report. *Precisions is a
measure of the degree of agreement for ART retention estimates from pharmacy stock records versus clinic cohort report estimates.
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firmation of whether all drugs collected from the main
pharmacy were actually given to patients at the ART fa-
cilities was difficult to collect. ART facilities, likely hospi-
tals, with this pharmacy set-up had substantial
differences in ART retention estimates between phar-
macy stock data and the clinic cohort report. Improved
and simplified pharmacy records systems are needed in
district hospitals to note drug transfers to other ART fa-
cilities more accurately and to ensure quality pharmacy
data. The model of ARV drug dispensing, common in
health centre pharmacies may be less prone to errors
caused by drug transfers. Health centres usually store
drugs in the nurse review room for direct drug dispensa-
tion to patients. The rooms have both ARV registers and
pharmacy stock cards, simplifying data recording and,
ultimately, leading to more accurate estimation of
patients retained on ART.Table 5 Comparison of time required to compile cohort repor
stock records in paper-based ART facilities
Clinic coh







*There were 5 ART facilities that used paper-based reporting systems in the periodAmong facilities with electronic data systems, the pilot
generally showed high levels of agreement of ART reten-
tion estimates between the cohort report generated elec-
tronically and the pharmacy stock records. This
similarity is likely because of the accuracy of the data in
the electronic system which in turn reduced variations
between the two sources. The high level of agreement
between the cohort report generated electronically and
the pharmacy stock records may indirectly confirms pre-
vious findings of the accuracy of data in the electronic
data system [7]. However, one ART facility, Mangochi
Hospital, adopted an electronic data system in quarter
three and showed quite low precision in that quarter.
The results from Mangochi were likely to be due to the
temporary challenges in transitioning from a paper-
based data system to an electronic data system. More-
over, as Mangochi had the largest number of patients on
ART, this finding may also indicate that the paper-basedts between paper-based cohort report andpharmacy
ort report Pharmacy stocks cards







between July and September 2010.
Tweya et al. BMC Health Services Research 2012, 12:210 Page 7 of 8
http://www.biomedcentral.com/1472-6963/12/210system may work effectively to a certain patient-number
threshold beyond which accuracy may decrease, necessi-
tating an electronic data system.
Addressing current challenges in management of phar-
macy stock records could make this a viable approach to
estimating patient retention in the future and would
provide several advantages over current estimate techni-
ques. First, estimation of ART retention based pharmacy
stock records is more cost-effective in terms of health-
care personnel time and effort. Second, pharmacy stock
records could help verify the accuracy, or identify weak-
nesses, in either paper- or electronic-based ART reten-
tion reports, providing an additional layer of monitoring
and verification for ART programs. Lastly, improving
pharmacy records for ART could have a trickle-down ef-
fect on improved general pharmacy record management
by ensuring an uninterrupted supply of drugs which is a
condition for life-long patient retention on ART and,
contributing to health system strengthening overall.
The results of this pilot study should be viewed in
light of the following limitations. First, pharmacy stock
cards were missing in some facilities due to poor hand-
over between pharmacy technicians, potentially leading
to underestimation of ART retention. In other facilities,
pharmacy records and ARV registers in facility clinic
rooms were incomplete reducing their use in estimating
patient retention. Moreover, in cases of low ARV stock
levels, ARV clinics may divide and share individual bot-
tles of ARVs, complicating calculations. But, as stock-out
events were not reported during the study period, this
probably did not affect the findings. Central hospitals
had some patients on non-standard ARV regimens, but
these patients could not be estimated from pharmacy
stock cards as the estimation process was not feasible.
As this was an observation pilot study, we did not con-
duct additional training on record management for the
pharmacist or nurses prior to the study which would
have improved the quality of pharmacy stock data and of
retention estimates. Lastly, in case of large discrepancies
in the estimates of patients retained on ART between
the two sources of information, we were unable to deter-
mine the more accurate monitoring system, especially in
paper-based facilities. However, we can hypothesise that
in such situations the data quality might be affected in
both monitoring systems, calling into question patient
retention in estimates at the specific facility regardless of
calculation method.
Conclusions
Overall, the pilot study found that estimates of ART
patients retained in care using pharmacy stock data were
largely similar to patient retention estimates calculated
using routine cohort report data collected from either
paper- or electronic-patient registers. Among facilitiesusing paper-based patient registers, using stock cards
reduced the time needed to compile the data more than
5-fold, a dramatic decrease in the personnel time
required for this routine reporting requirement. While
electronic pharmacy management systems supported by
well-trained personnel would be ideal, addressing
current challenges in ARV stock management would
likely make pharmacy stock cards a viable and cost-
effective option for estimating patients retained on ART
especially among facilities still using paper-based patient
registries. Additional studies to explore the accuracy,
feasibility and costs of using pharmacy stock data in
other low-resource settings would strengthen these
results and could lead to scale-up of this less time inten-
sive method for patient retention estimation across sub-
Saharan Africa.
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